Abstract:Journal of Dental Research, Ahead of Print. RUNX2 is a master osteogenic transcription factor, and mutations in RUNX2 cause the inherited skeletal disorder cleidocranial dysplasia (CCD). Studies have revealed that RUNX2 is not only a downstream target of the bone morphogenetic protein (BMP) pathway but can also regulate the expression of BMPs. However, the underlying mechanism of the regulation of BMPs by RUNX2 remains unknown. In this project, we diagnosed a CCD patient with a 7.86-Mb heterozygous deletion on chromosome 6 containing all exons of RUNX2 by multiplex ligation-dependent probe amplification (MLPA) and whole-genome sequencing (WGS). Bone marrow mesenchymal stem cells (BMSCs) were further extracted from patient alveolar bone fragments (CCD-BMSCs), an excellent natural model to explore the possible mechanism. The osteogenic differentiation ability of CCD-BMSCs was severely affected by RUNX2 heterozygous deletion. Also, BMP4 decreased most in BMP ligands, and CHRDL1, a BMP antagonist, was abnormally elevated in CCD-BMSCs. Furthermore, BMP4 treatment essentially rescued the osteogenic capacity of CCD-BMSCs, and RUNX2 overexpression reversed the abnormal expression of BMP4 and CHRDL1. Notably, we constructed CRISPR/Cas9 Runx2+/m MC3T3-E1 cells, which simulated a variant in CCD-BMSCs, to exclude the interference of other gene deletions and the heterogeneity of the genetic background of primary cells, and verified all findings from the CCD-BMSCs. Moreover, the luciferase reporter experiment showed that RUNX2 could inhibit the transcription of CHRDL1. Through immunofluorescence, the inhibitory effect of CHRDL1 on BMP4/Smad signaling was confirmed in MC3T3-E1 cells. These results revealed that RUNX2 regulated the BMP4 pathway by inhibiting CHRDL1 transcription. We collectively identified a novel RUNX2/CHRDL1/BMP4 axis to regulate osteogenic differentiation and noted that BMP4 might be a valuable therapeutic option for treating bone diseases.

RUNX2 mutation reduces osteogenic differentiation of dental follicle cells in cleidocranial dysplasia

Effect of Cleidocranial Dysplasia‐related Novel Mutation of RUNX2 on Characteristics of Dental Pulp Cells and Tooth Development

A Novel RUNX2 Mutation in Cleidocranial Dysplasia Patients.

RUNX2 mutation impairs osteogenic differentiation of dental follicle cells

Mutations in the RUNX2 Gene in Chinese Patients with Cleidocranial Dysplasia.

RUNX2 mutation impairs bone remodelling of dental follicle cells and periodontal ligament cells in patients with cleidocranial dysplasia

Effect And Possible Mechanism Of Network Between Micrornas And Runx2 Gene On Human Dental Follicle Cells

Identification of human dental follicle cells with RUNX2 gene mutation

Mutations in the RUNX2 gene in a patient with Cleidocranial Dysplasia

RUNX2 Mutation Impairs 1α,25-Dihydroxyvitamin D3 mediated Osteoclastogenesis in Dental Follicle Cells

Mutation Analysis of the RUNX2 Gene in a Family with Cleidocranial Dysplasia

RUNX2 Mutation Impairs 1Α,25-Dihydroxyvitamin D 3 Mediated Osteoclastogenesis in Dental Follicle Cells

Abnormal bone remodelling activity of dental follicle cells from a cleidocranial dysplasia patient

Abnormal bone remodeling activity of dental follicle cells from a cleidocranial dysplasia patient.

A Study on the Ultrastructure of Hypocalcification in Patient with Cleidocranial Dysostosis

RUNX2 mutation inhibits the cellular senescence of dental follicle cells via ERK signalling pathway

Effect of the RUNX2 Gene Mutations on Subnuclear Localization of the RUNX2 Protein Mutants

Abnormal differentiation of dental pulp cells in cleidocranial dysplasia

RUNX2 mutations in cleidocranial dysplasia

RUNX2 Regulates Osteoblast Differentiation via the BMP4 Signaling Pathway

Effect of RUNX2 mutation on tranforming grouth factor-β relevant signal passway in dental pulp cells